DNA microarrays, which have been increasingly used to examine global gene expression in different areas of nutritional science, are a rich source of information. Bioinformatic analysis of microarray datasets provides an insight into the major networks and key pathways that are altered in a particular situation or in response to a specific stimulus – whether nutritional, hormonal or environmental. These pathways and networks, together with the identification of the genes whose expression is altered most substantially, are usually of most interest. This is undoubtedly the case during the first phases of analysis, and the ensuing publication(s) will invariably focus on the major changes occurring in response to the particular stimulus. Frequently, there may be little further mining of the datasets. However, continued exploration of microarray data can yield considerable additional information and provide unexpected insight, either on specific genes and groups of genes, or on less prominent pathways and networks. This does not necessarily require complex bioinformatics, but may relate to a targeted interest in particular genes or metabolic processes.
An example of this additional insight comes from studies that we have conducted on human adipocytes exposed to an inflammatory stimulus in the form of incubation with macrophage-conditioned medium(Reference O'Hara, Lim and Mazzatti1). The initial bioinformatic analysis indicated that the pathways that were most strongly modulated on exposure of the fat cells to signals from macrophages are those associated with inflammation, glucose uptake and macrophage infiltration(Reference O'Hara, Lim and Mazzatti1). The most highly up-regulated genes were a group of matrix metalloproteinases: the MMP1, MMP3 and MMP10 genes each exhibited >1000-fold increase in mRNA level in the adipocytes after 24 h exposure to macrophage-conditioned medium, while 200–400-fold increases in MMP9 and MMP12 expression were evident(Reference O'Hara, Lim and Mazzatti1). Subsequent analysis of the datasets has indicated that the expression of genes associated with vitamin D3 metabolism is also modulated in the adipocytes by macrophage secretions. There was, in particular, a substantial stimulation in the expression of the CYP27B1 gene (82-fold increase in mRNA level after 24 h) which encodes the 25(OH)D3-1α-hydroxylase that catalyses the conversion of 25-hydroxycholecalciferol to the active vitamin D3 hormone, 1,25-dihydroxycholecalciferol(Reference Trayhurn, O'Hara and Bing2). Expression of the nuclear vitamin D receptor gene, VDR, was also increased (7·7-fold elevation in mRNA after 24 h). These observations indicate that the ability of adipocytes to synthesise the biologically active vitamin D3 hormone, and to act as a target for the hormone, is markedly stimulated during inflammation, consistent with an anti-inflammatory action of vitamin D3 in adipose tissue(Reference Trayhurn, O'Hara and Bing2).
Further targeted mining of the microarrays for genes associated with nutrient metabolism has revealed insight into the effects of macrophage secretions on the expression in adipocytes of the G-protein-coupled receptors (GPR) that act as fatty acid receptors and sensors. These GPR fatty acid receptors/sensors have been the focus of considerable interest recently, particularly in relation to inflammation and insulin sensitivity, and several are now recognised – GPR40, GPR41, GPR43, GPR84 and GPR120, each of which has a different selectivity(Reference Talukdar, Olefsky and Osborn3). GPR40 (also known as FFAR1) binds long-chain fatty acids(Reference Briscoe, Tadayyon and Andrews4, Reference Itoh, Kawamata and Harada5), while GPR41 (FFAR3) and GPR43 (FFAR2) are receptors for SCFA(Reference Brown, Goldsworthy and Barnes6, Reference Tazoe, Otomo and Kaji7). GPR84 is selective for medium-chain fatty acids(Reference Wang, Wu and Simonavicius8), while GPR120 has recently been shown to be a receptor for n-3 PUFA(Reference Oh, Talukdar and Bae9). Each of the GPR fatty acid receptors has been reported to be expressed in (white) adipose tissue, with strong expression, relative to other tissues, of GPR43 and GPR120 in particular(Reference Briscoe, Tadayyon and Andrews4, Reference Brown, Goldsworthy and Barnes6, Reference Wang, Wu and Simonavicius8, Reference Oh, Talukdar and Bae9). GPR120 is expressed strongly in white adipocytes (3T3-L1 cells) themselves, expression being differentiation dependent; it is also highly expressed in macrophage and monocyte cell lines(Reference Oh, Talukdar and Bae9). Although a high expression of GPR41 was originally reported in adipose tissue, subsequent studies have found little or no expression in the tissue(Reference Oh, Talukdar and Bae9–Reference Zaibi, Stocker and O'Dowd11).
Several roles have been demonstrated for the different GPR fatty acid receptors/sensors. For example, GPR40 is involved in the glucose-induced stimulation of insulin secretion from pancreatic β-cells(Reference Itoh, Kawamata and Harada5), while SCFA stimulate glucagon-like protein-1 secretion from colonic cells and leptin secretion from adipocytes through GPR43(Reference Tolhurst, Heffron and Lam12). Both GPR84 and GPR120 have been implicated in inflammation. A recent report has indicated that in murine 3T3-L1 adipocytes incubation with TNFα, or co-culture with a macrophage cell line, leads to marked stimulation of GPR84 gene expression, with medium-chain fatty acids inhibiting adiponectin expression via this receptor(Reference Nagasaki, Kondo and Fuchigami13). More importantly, GPR120 has been shown to mediate the anti-inflammatory and insulin-sensitising effects of n-3 PUFA, ameliorating inflammation-induced insulin resistance in obesity(Reference Oh, Talukdar and Bae9). GPR120 knockout mice are more insulin resistant than wild-type controls, and when fed a high-fat diet supplementation with n-3 fish oils did not reverse their insulin resistance, in contrast to the wild-type animals(Reference Talukdar, Olefsky and Osborn3, Reference Oh, Talukdar and Bae9). The knockout mice are also reported to develop obesity on a high-fat diet, and exhibit a fatty liver and reduced adipogenesis(Reference Ichimura, Hirasawa and Poulain-Godefroy14).
Analysis of our microarray datasets showed no change in GPR40 and GPR43 mRNA levels following exposure of human adipocytes to macrophage-conditioned medium (Table 1); no signal was obtained for GPR41. However, increases in GPR84 expression were observed, at both 4 and 24 h of incubation with conditioned medium, the mRNA level being increased 13·5-fold at 24 h relative to the adipocytes incubated with unconditioned medium (Table 1). This observation, from human adipocytes, is consistent with the demonstration that GPR84 gene expression in 3T3-L1 adipocytes is stimulated by TNFα and macrophage-secreted factors(Reference Nagasaki, Kondo and Fuchigami13). Up-regulation of GPR84 receptor expression by inflammatory mediators would be predicted to lead to an accentuation of the inflammatory response in fat cells.
nd, Not detected.
† Gene expression was determined with Agilent microarrays following incubation of human Simpson–Golabi–Behmel syndrome (SGBS)(Reference Wabitsch, Brenner and Melzner19) adipocytes with macrophage-conditioned medium, or unconditioned medium (controls), for either 4 or 24 h(Reference O'Hara, Lim and Mazzatti1). The adipocytes were differentiated from fibroblastic preadipocytes in primary culture and were used at 10 d after the induction of differentiation. The fold-change relates to the conditioned medium compared with unconditioned medium (controls).
** Value was significantly different from that of controls (P < 0.01).
In contrast to the other GPR fatty acid receptors, there was a marked reduction in GPR120 expression in human adipocytes exposed to macrophage-conditioned medium, the mRNA level being reduced by as much as 15-fold after 24 h (Table 1). Thus, macrophage-secreted factors induce a substantial down-regulation of the expression of the gene encoding the major receptor/sensor for n-3 fatty acids. The decrease in the receptor (assuming that the changes in gene expression are accompanied by a reduction in the receptor protein) in adipocytes would presumably, and paradoxically, compromise the well-recognised and extensive anti-inflammatory action of these fatty acids(Reference Calder15, Reference Calder, Albers and Antoine16). This suggests that such fatty acids may have a more limited inhibitory effect on inflammation and insulin resistance in adipocytes, at least that induced by macrophages, than might be expected. The microarray data based on the response to macrophage-conditioned medium needs to be followed by a detailed investigation of the effects of more specific inflammatory stimuli, such as lipopolysaccharide and TNFα, on adipocyte GPR120 expression and cellular GPR120 protein content. This includes the interaction with n-3 fatty acids.
It is noteworthy that macrophage secretions simultaneously up-regulate GPR84 and down-regulate GPR120 expression in human adipocytes, both effects being likely to lead to an amplification of the fat cell inflammatory response. The present analysis highlights the involvement of the GPR fatty acid receptors/sensors in inflammation in adipose tissue, and demonstrates clear differences in response in adipocytes between the key receptors/sensors. It also raises the possibility that the anti-inflammatory effect of n-3 fatty acids from fish oils may be attenuated in adipose tissue in obesity because of the extensive recruitment of macrophages into the tissue(Reference Weisberg, McCann and Desai17, Reference Xu, Barnes and Yang18). Finally, the present article illustrates the richness of information that is available in microarray datasets and which can be obtained in nutritional (and other) studies by repeated, targeted mining without the need for complex bioinformatic analysis.
Acknowledgements and disclosures
P. T. is grateful to Professor Ian Caterson for the invitation to the Boden Institute, University of Sydney, and to the Sydney University Nutrition Research Foundation for funding his visit. The contribution of Dr Adrian O'Hara (University of Liverpool), and of Dr Dawn Mazzatti and Dr Fei-Lim Ling (Unilever plc) is gratefully acknowledged. The authors declare that there are no conflicts of interest, financial or otherwise. Both authors were involved in the analysis of the microarray data, G. D. developing the software. P. T. drafted the manuscript with G. D. providing editorial comments.